Sapience Therapeutics
PrivateLast Round
Grant
May 4, 2023
Total Funding Raised
$65.76M
Momentum Score
25 /100
Company Overview
Sapience Therapeutics is a biotechnology company focused on developing peptide disrupters that target oncogenic and immune dysregulation to combat cancer and other serious medical conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sapience Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Sapience Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 4, 2023 | ||||
| Series B | May 31, 2022 | ||||
| VC Round | Nov 17, 2020 | ||||
| Grant | Aug 19, 2020 | ||||
| Series A | Jul 12, 2016 |
Key People
Founding team and executive leadership
Sapience Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Eshelman Ventures | VC Round, Series A, Series B |
| Columbia Technology Ventures | Series A |
| Kingdon Capital Management | Series B |
| NexPoint Capital, Inc. | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 13, 2026
Attended the 25th Annual Needham Virtual Healthcare Conference.
Sapience Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sapience Therapeutics's valuation, stock price, and market status.
